Showing 1 - 10 of 268
Moderna says US refusing to review mRNA-based flu shot
AFP, Published on 11/02/2026
» NEW YORK - Vaccine manufacturer Moderna said on Tuesday the US Food and Drug Administration (FDA) was refusing to review an application for its first mRNA-based flu shot.
US approves new Moderna Covid jab for over-65s
Reuters, Published on 31/05/2025
» WASHINGTON - The US Food and Drug Administration has approved Moderna’s next-generation Covid-19 vaccine for everyone aged 65 and above, the company said on Saturday, the first endorsement since the regulator tightened requirements.
US drops some Covid vaccine recommendations
Reuters, Published on 27/05/2025
» WASHINGTON - The US Centers for Disease Control and Prevention has stopped recommending routine Covid-19 vaccinations for pregnant women and healthy children, health regulators said on Tuesday.
Katalin Kariko, scientific maverick who paved way for mRNA vaccines
AFP, Published on 02/10/2023
» WASHINGTON - Hungarian-born scientist Katalin Kariko's obsession with researching a substance called mRNA to fight disease once cost her a faculty position at a prestigious US university, which dismissed the idea as a dead end.
Nobel prize goes to mRNA Covid vaccine researchers
AFP, Published on 02/10/2023
» STOCKHOLM: Katalin Kariko and Drew Weissman won the Nobel Medicine Prize on Monday for work on messenger RNA (mRNA) technology that paved the way for groundbreaking Covid-19 vaccines.
Covid's back: Here's what to know this fall and winter
AFP, Published on 13/09/2023
» WASHINGTON - As colder weather sets in, Covid rates are once more rising across the Northern Hemisphere, with several new variants on the scene.
Global Covid cases up 80% as new subvariant rises
AFP, Published on 11/08/2023
» PARIS: The number of new Covid-19 cases reported worldwide rose by 80% in the last month, the World Health Organization said on Friday, days after designating a new "variant of interest".
First post-Covid jab claims land in German courts
AFP, Published on 12/06/2023
» FRANKFURT (GERMANY) - German courts will from Monday begin examining a series of claims over adverse effects suffered after coronavirus vaccinations, more than two years after one of the world's fastest and most extensive innoculation campaigns.
US issues world's first approval of RSV vaccine
AFP, Published on 04/05/2023
» WASHINGTON - The United States on Wednesday approved the world's first vaccine for the Respiratory Syncytial Virus (RSV), the culmination of a decades long hunt to protect vulnerable people from the common illness.
US approves world's first RSV vaccine
AFP, Published on 04/05/2023
» WASHINGTON - The United States on Wednesday approved GSK's Arexy vaccine against Respiratory Syncytial Virus (RSV), which can cause severe pneumonia and bronchiolitis in infants and the elderly.